Patents by Inventor Kwan Han

Kwan Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210375214
    Abstract: A display device includes the following elements: a display panel comprising pixels; a data driver supplying data signals to the plurality of pixels; a driving voltage supply supplying a first driving voltage to the data driver; a power supply supplying a first input driving voltage to the driving voltage supply; and a timing controller providing control signals to the data driver, the driving voltage supply, and the power supply and providing luminance information and per-second frame rate information of the display panel to the driving voltage supply. The driving voltage supply comprises an input driving voltage adjuster which adjusts the first input driving voltage to a second input driving voltage based on the luminance information and the per-second frame rate information.
    Type: Application
    Filed: January 28, 2021
    Publication date: December 2, 2021
    Inventors: Hyun Chang KIM, Sung Chun PARK, Dong Kwan HAN
  • Publication number: 20210308096
    Abstract: The present disclosure relates to a composition for preventing, improving or treating pruritus by using a naturally derived ingredient. The composition of the present disclosure may be used to improve or treat pruritus caused by various causes safely and effectively without the risk of side effects.
    Type: Application
    Filed: June 18, 2021
    Publication date: October 7, 2021
    Applicants: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY, STEMDR INC.
    Inventors: Myung-Kwan HAN, Hern-Ku LEE, So-Jeong KIM, Suhn-Young IM, Baik-Hwan CHO, Jeong-Soo PARK
  • Patent number: 11135250
    Abstract: The present disclosure relates to a novel musculoskeletal stem cell (MSSC) differentiated from an ESC (embryonic stem cell) or an iPSC (induced pluripotent stem cell). The musculoskeletal stem cell of the present disclosure can be easily induced from a human embryonic stem cell or a human-derived pluripotent stem cell and can be effectively differentiated not only into bone but also into cartilage, tendon and muscle. Accordingly, it can be usefully used for prevention or treatment of various musculoskeletal diseases.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: October 5, 2021
    Assignee: Cellatoz Therapeutics, Inc.
    Inventor: Myung-Kwan Han
  • Publication number: 20210281175
    Abstract: A voltage converter includes an input voltage line; an inductor coupled to the input voltage line; transistors coupled to the inductor; an output voltage line coupled to at least one of the transistors; a current sensor coupled to at least one of the input voltage line, the inductor, or the output voltage line; and a comparator coupled between the current sensor and the transistors. A DC-DC converter may include a voltage converter having an inductor and a plurality of transistors and configured to convert an input voltage into a power voltage and output the power voltage to an output terminal, an input current sensor configured to sense the input current of the converter, and a controller configured to change the slew rate of an inductor voltage in response to the input current of the converter and a preset reference current.
    Type: Application
    Filed: October 1, 2020
    Publication date: September 9, 2021
    Inventor: DONG KWAN HAN
  • Publication number: 20210009958
    Abstract: The present disclosure relates to a novel musculoskeletal stem cell (MSSC) differentiated from an ESC (embryonic stem cell) or an iPSC (induced pluripotent stem cell). The musculoskeletal stem cell of the present disclosure can be easily induced from a human embryonic stem cell or a human-derived pluripotent stem cell and can be effectively differentiated not only into bone but also into cartilage, tendon and muscle. Accordingly, it can be usefully used for prevention or treatment of various musculoskeletal diseases.
    Type: Application
    Filed: October 24, 2018
    Publication date: January 14, 2021
    Inventor: Myung-Kwan HAN
  • Publication number: 20200316001
    Abstract: The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.
    Type: Application
    Filed: November 23, 2018
    Publication date: October 8, 2020
    Applicants: STEMDR INC., INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY, KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventor: Myung-Kwan HAN
  • Patent number: 10576106
    Abstract: The present disclosure relates to a novel musculoskeletal stem cell (MSSC) differentiated from an ESC (embryonic stem cell) or an iPSC (induced pluripotent stem cell). The musculoskeletal stem cell of the present disclosure can be easily induced from a human embryonic stem cell or a human-derived pluripotent stem cell and can be effectively differentiated not only into bone but also into cartilage, tendon and muscle. Accordingly, it can be usefully used for prevention or treatment of various musculoskeletal diseases.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: March 3, 2020
    Assignee: Cellatoz Therapeutics, Inc.
    Inventor: Myung-Kwan Han
  • Publication number: 20200030283
    Abstract: The present disclosure relates to a composition for preventing, improving or treating pruritus by using a naturally derived ingredient. The composition of the present disclosure may be used to improve or treat pruritus caused by various causes safely and effectively without the risk of side effects.
    Type: Application
    Filed: December 12, 2017
    Publication date: January 30, 2020
    Applicants: INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY, STEMDR INC.
    Inventors: Myung-Kwan HAN, Hern-Ku LEE, So-Jeong KIM, Suhn-Young IM, Baik-Hwan CHO, Jeong-Soo PARK
  • Publication number: 20190247441
    Abstract: The present disclosure relates to a novel musculoskeletal stem cell (MSSC) differentiated from an ESC (embryonic stem cell) or an iPSC (induced pluripotent stem cell). The musculoskeletal stem cell of the present disclosure can be easily induced from a human embryonic stem cell or a human-derived pluripotent stem cell and can be effectively differentiated not only into bone but also into cartilage, tendon and muscle. Accordingly, it can be usefully used for prevention or treatment of various musculoskeletal diseases.
    Type: Application
    Filed: April 23, 2019
    Publication date: August 15, 2019
    Inventor: Myung-Kwan HAN
  • Patent number: 10346240
    Abstract: A repair information providing device in an integrated circuit including a plurality of memory blocks includes a plurality of faulty cell address registers connected to the memory blocks, respectively, a repair information storage block configured to store repair information including an address of a faulty cell and a memory index indicating a memory block having the faulty cell, a repair information control block configured to read the repair information from the repair information storage block, transfer the address of the faulty cell included in the repair information to the respective faulty cell address registers, and generate a memory block selection signal based on the memory index included in the repair information, and a clock gating block configured to receive a clock signal, and selectively transfer the clock signal to one of the faulty cell address registers connected to the memory block having the faulty cell in response to receiving the memory block selection signal.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: July 9, 2019
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Ju-Hee Han, Yo-Seop Lim, Dong-Kwan Han
  • Publication number: 20190090502
    Abstract: Disclosed herein is a whole-bean soymilk having an increased level of deglycosylated soy isoflavones and a method of preparing thereof. The method includes the steps of subjecting a mixture of a soybean material and water to a comminution treatment so as to obtain a soybean slurry, subjecting the soybean slurry to an enzymatic hydrolysis treatment using a ?-glucosidase to obtain a hydrolysate, and subjecting the hydrolysate to a media milling treatment using a milling medium.
    Type: Application
    Filed: September 11, 2018
    Publication date: March 28, 2019
    Inventors: Kwan-Han CHEN, Hung-Chi HSIAO, Hui-Min LAI, Chien-Yu CHEN, Chia-Ching LI, Yi-Shian WANG, Ming-Chi TSAI
  • Publication number: 20190090500
    Abstract: The subject invention aims to solve the problem of production of glucose accompanying the production of galactooligosaccharides after milk raw material is treated with lactase, by additionally adding transglucosidase to convert glucose to functional isomalto-oligosaccharide. The subject invention relates to a process for the production of a milk product enhanced with oligo-saccharides, characterized in that lactase and transglucosidase are used to treat milk raw materials. The subject invention further relates to the milk product of the process of the invention, whose oligo-saccharide content reaches a functional level. Human physiological effect assays confirm that the milk product increases intestinal probiotics, reduces harmful intestinal bacteria, improves the intestinal bacterial flora, reduces blood total cholesterol, reduces blood LDL cholesterol, increases blood HDL cholesterol, and improves the immunity, and may be used as low glycemic index (GI) dietary supplements.
    Type: Application
    Filed: September 25, 2018
    Publication date: March 28, 2019
    Applicant: A.G.V. PRODUCTS CORP.
    Inventors: Kwan-Han CHEN, Hung-Chi HSAIO, Hui-Min LAI, Chien-Yu CHEN, Chia-Ching LI, Yi-shian WANG, Ming-chi TSAI
  • Publication number: 20180161398
    Abstract: The present invention relates to a composition containing an inducer of SIRT1 (silent mating type information regulation 2 homolog) expression for preventing or treating sepsis or septic shock. The inducer of SIRT1 expression can remarkably reduce the mortality caused by sepsis or septic shock by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines. Therefore, the inducer of SIRT1 expression is useful for preventing or treating sepsis or septic shock.
    Type: Application
    Filed: February 6, 2018
    Publication date: June 14, 2018
    Inventors: Myung Kwan HAN, Chae Hwa YOO, Eun Kyung SONG, Seung Ok LEE
  • Patent number: 9913880
    Abstract: The present invention relates to a composition containing an inducer of SIRT1 (silent mating type information regulation 2 homolog) expression for preventing or treating sepsis or septic shock. The inducer of SIRT1 expression can remarkably reduce the mortality caused by sepsis or septic shock by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines. Therefore, the inducer of SIRT1 expression is useful for preventing or treating sepsis or septic shock.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: March 13, 2018
    Assignee: STEMDR INC.
    Inventors: Myung Kwan Han, Chae Hwa Yoo, Eun Kyung Song, Seung Ok Lee
  • Patent number: 9774963
    Abstract: The present invention relates to an ear wing including: a coupling portion coupled to a sound output device; a deformable fixing portion deformed with a curvature to correspond to the shape of the antihelix in such a manner as to be located inside the antihelix and for fixing the position of the coupling portion to an external ear; and a variable portion for connecting the coupling portion and the deformable fixing portion in such a manner as to support the deformable fixing portion thereagainst and having at least one or more variable parts changed in shape according to the deformation of the deformable fixing portion.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: September 26, 2017
    Inventor: Seung Kwan Han
  • Publication number: 20170257714
    Abstract: The present invention relates to an ear wing including: a coupling portion coupled to a sound output device; a deformable fixing portion deformed with a curvature to correspond to the shape of the antihelix in such a manner as to be located inside the antihelix and for fixing the position of the coupling portion to an external ear; and a variable portion for connecting the coupling portion and the deformable fixing portion in such a manner as to support the deformable fixing portion thereagainst and having at least one or more variable parts changed in shape according to the deformation of the deformable fixing portion.
    Type: Application
    Filed: March 31, 2016
    Publication date: September 7, 2017
    Inventor: Seung Kwan HAN
  • Patent number: 9606182
    Abstract: A system on chip (SOC) is provided. The system on chip (SOC) includes: at least one core including a plurality of scan chains operated by a trigger signal; a delay controller generating a delay target selection signal selecting at least one of the plurality of scan chains and a delay depth control signal indicating a delay depth of the trigger signal; and a delay signal generating unit delaying the trigger signal based on the delay target selection signal and the delay depth control signal and providing the delayed trigger signal to the plurality of scan chains.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: March 28, 2017
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Dong-kwan Han, Ji-hye Kim
  • Patent number: D900616
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: November 3, 2020
    Assignee: Taiwan First Biotechnology Corp.
    Inventor: Kwan-Han Chen
  • Patent number: D900618
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: November 3, 2020
    Assignee: Taiwan First Biotechnology Corp.
    Inventor: Kwan-Han Chen
  • Patent number: D917293
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: April 27, 2021
    Assignee: Taiwan First Biotechnology Corp.
    Inventor: Kwan-Han Chen